Corvus Pharmaceuticals (CRVS) Other Non-Current Liabilities (2015 - 2025)
Corvus Pharmaceuticals (CRVS) recorded quarterly Other Non-Current Liabilities of $3.8 million in Q1 2025, down 86.92% quarter-over-quarter from $28.9 million in Q4 2024.
Corvus Pharmaceuticals (CRVS) Other Non-Current Liabilities (2015 - 2025) Analysis & Trends
Corvus Pharmaceuticals' Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $3.8 million for Q1 2025.
- In Q1 2025, Other Non-Current Liabilities changed N/A year-over-year to $3.8 million; the TTM figure through Mar 2025 stood at $3.8 million (changed N/A YoY), while the FY2024 annual figure was $28.9 million, changed N/A from the prior year.
- Other Non-Current Liabilities was $3.8 million for Q1 2025 at Corvus Pharmaceuticals, down from $28.9 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $40.0 million in Q3 2024 to a low of $3.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Corvus Pharmaceuticals | 1.00 Bn | 766.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.78 Mn |
| Dec 31, 2024 | 28.91 Mn |
| Sep 30, 2024 | 39.96 Mn |
| Jun 30, 2024 | 7.10 Mn |
| Dec 31, 2018 | 869,000.00 |
| Sep 30, 2018 | 627,000.00 |
| Jun 30, 2018 | 741,000.00 |
| Mar 31, 2018 | 857,000.00 |
| Dec 31, 2017 | 971,000.00 |
| Sep 30, 2017 | 1.08 Mn |
| Jun 30, 2017 | 1.19 Mn |
| Mar 31, 2017 | 1.30 Mn |
| Dec 31, 2016 | 1.41 Mn |
| Sep 30, 2016 | 1.26 Mn |
| Jun 30, 2016 | 1.35 Mn |
| Mar 31, 2016 | 1.29 Mn |
| Dec 31, 2015 | 710,000.00 |